Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 12:37 AM
NCT ID:
NCT02443467
Eligibility Criteria:
Inclusion Criteria:
* Female patients \> or = 18 years of age
* Human Epidermal Growth Factor Receptor 2 (HER2)-neu overexpression
* Previously treated with adjuvant antracycline containing chemotherapy
* Left Ventricular Ejection Fraction (LVEF) \> 50%
* Eastern Cooperative Oncology Group (ECOG) score \< or = 2
* Life expectancy \> or = 12 weeks
Exclusion Criteria:
* Left Ventricular Ejection Fraction (LVEF) \< 50%
* Advanced pulmonary disease
* Severe dyspnea
* Abnormal laboratory results within 14 days prior to registration
* Peripheral neuropathy
* Presence of Central Nervous System (CNS) metastasis
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02443467
Study Brief:
Protocol Section:
NCT02443467